Anchor Investment Management’s Gilead Sciences GILD Stock Holding History

Anchor Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$41.8K	Hold	300	–	–	﹤0.01%	608
2025 Q4	$36.8K	Hold	300	–	–	﹤0.01%	637
2025 Q3	$33.3K	Hold	300	–	–	﹤0.01%	653
2025 Q2	$33.3K	Hold	300	–	–	﹤0.01%	637
2025 Q1	$33.6K	Hold	300	–	–	﹤0.01%	626
2024 Q4	$27.7K	Hold	300	–	–	﹤0.01%	660
2024 Q3	$25.2K	Hold	300	–	–	﹤0.01%	667
2024 Q2	$20.6K	Hold	300	–	–	﹤0.01%	646
2024 Q1	$22K	Hold	300	–	–	﹤0.01%	665
2023 Q4	$24.3K	Hold	300	–	–	﹤0.01%	625
2023 Q3	$22.5K	Hold	300	–	–	﹤0.01%	634
2023 Q2	$23.1K	Hold	300	–	–	﹤0.01%	624
2023 Q1	$24.9K	Sell	300 -375	-56%	-$31.1K	﹤0.01%	638
2022 Q4	$57.9K	Hold	675	–	–	0.01%	497
2022 Q3	$41.6K	Buy	675 +50	+8%	+$3.15K	0.01%	538
2022 Q2	$38.6K	Sell	625 -11	-2%	-$681	0.01%	567
2022 Q1	$37.8K	Buy	636 +100	+19%	+$6.39K	﹤0.01%	587
2021 Q4	$38.9K	Hold	536	–	–	﹤0.01%	598
2021 Q3	$37.4K	Hold	536	–	–	0.01%	559
2021 Q2	$36.9K	Hold	536	–	–	0.01%	573
2021 Q1	$34.6K	Hold	536	–	–	0.01%	558
2020 Q4	$31.2K	Hold	536	–	–	0.01%	537
2020 Q3	$33.9K	Sell	536 -173	-24%	-$12K	0.01%	498
2020 Q2	$54.5K	Buy	709 +45	+7%	+$3.45K	0.01%	421
2020 Q1	$49.6K	Sell	664 -4,649	-88%	-$321K	0.01%	418
2019 Q4	$345K	Sell	5,313 -2,115	-28%	-$138K	0.07%	211
2019 Q3	$471K	Sell	7,428 -336	-4%	-$22K	0.11%	179
2019 Q2	$525K	Sell	7,764 -441	-5%	-$29K	0.13%	164
2019 Q1	$533K	Sell	8,205 -565	-6%	-$37.6K	0.13%	158
2018 Q4	$549K	Sell	8,770 -4,066	-32%	-$284K	0.16%	142
2018 Q3	$991K	Sell	12,836 -408	-3%	-$30.8K	0.23%	122
2018 Q2	$938K	Buy	13,244 +905	+7%	+$63.9K	0.23%	119
2018 Q1	$930K	Buy	12,339 +74	+0.6%	+$5.88K	0.24%	111
2017 Q4	$879K	Sell	12,265 -209	-2%	-$15.9K	0.23%	112
2017 Q3	$1.01M	Sell	12,474 -22	-0.2%	-$1.68K	0.3%	94
2017 Q2	$884K	Sell	12,496 -575	-4%	-$38.3K	0.29%	87
2017 Q1	$888K	Buy	13,071 +10,408	+391%	+$732K	0.31%	86
2016 Q4	$191K	Buy	2,663 +5	+0.2%	+$372	0.07%	230
2016 Q3	$210K	Sell	2,658 -3,030	-53%	-$246K	0.08%	217
2016 Q2	$474K	Sell	5,688 -1,500	-21%	-$133K	0.19%	122
2016 Q1	$660K	Buy	+7,188	New	+$648K	0.27%	97

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Anchor Investment Management's GILD Position: Q1 2026 in Review

Anchor Investment Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 300 shares worth $41.8K. The position accounts for ﹤0.01% of the portfolio, ranked #608.

Anchor Investment Management first reported a position in GILD in Q1 2016 and has held it in 41 quarters since. The position peaked at $1.01M in Q3 2017. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Anchor Investment Management held 300 shares of Gilead Sciences worth $41.8K as of Q1 2026.
Anchor Investment Management left its Gilead Sciences share count unchanged in Q1 2026.
Gilead Sciences made up ﹤0.01% of Anchor Investment Management's portfolio in Q1 2026, its #608 holding.
Anchor Investment Management first reported a position in Gilead Sciences in Q1 2016 and has held it in 41 quarters since.
Anchor Investment Management's Gilead Sciences position peaked at $1.01M in Q3 2017.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.